|
Gil-Martinez AL, Cuenca-Bermejo L, Gonzalez-Cuello AM, Sanchez-Rodrigo C, Parrado A, Vyas S, Fernandez-Villalba E, Herrero MT. Identification of differentially expressed genes profiles in a combined mouse model of Parkinsonism and colitis. Sci Rep. 2020 Aug 4;10(1):13147. doi: 10.1038/s41598-020-69695-4. PubMed PMID: 32753609; PubMed Central PMCID: PMC7403295.
AÑO: 2020; IF: 4.379
|
32753609
|
Navarro-Zaragoza J, Cuenca-Bermejo L, Almela P, Laorden ML, Herrero MT. Could Small Heat Shock Protein HSP27 Be a First-Line Target for Preventing Protein Aggregation in Parkinson's Disease? Int J Mol Sci. 2021 Mar 16;22(6):3038. doi: 10.3390/ijms22063038. PubMed PMID: 33809767; PubMed Central PMCID: PMC8002365.
AÑO: 2021; IF: 6.208
|
|
Cuenca-Bermejo L, Almela P, Navarro-Zaragoza J, Fernandez Villalba E, Gonzalez-Cuello AM, Laorden ML, Herrero MT. Cardiac Changes in Parkinson's Disease: Lessons from Clinical and Experimental Evidence. Int J Mol Sci. 2021 Dec 16;22(24):13488. doi: 10.3390/ijms222413488. PubMed PMID: 34948285; PubMed Central PMCID: PMC8705692.
AÑO: 2021; IF: 6.208
|
|
Teil M, Dovero S, Bourdenx M, Arotcarena ML, Camus S, Porras G, Thiolat ML, Trigo-Damas I, Perier C, Estrada C, Garcia-Carrillo N, Morari M, Meissner WG, Herrero MT, Vila M, Obeso JA, Bezard E, Dehay B. Brain injections of glial cytoplasmic inclusions induce a multiple system atrophy-like pathology. Brain. 2022 Apr 29;145(3):1001-1017. doi: 10.1093/brain/awab374. PubMed PMID: 35285474.
AÑO: 2022; IF: 14.5
|
|
De Araujo FM, Frota AF, de Jesus LB, Macedo TC, Cuenca-Bermejo L, Sanchez-Rodrigo C, Ferreira KMS, de Oliveira JVR, de Fatima Dias Costa M, Segura-Aguilar J, Costa SL, Herrero MT, Silva VDA. Aminochrome Induces Neuroinflammation and Dopaminergic Neuronal Loss: A New Preclinical Model to Find Anti-inflammatory and Neuroprotective Drugs for Parkinson's Disease. Cell Mol Neurobiol. 2023 Jan;43(1):265-281. doi: 10.1007/s10571-021-01173-5. Epub 2022 Jan 6. PubMed PMID: 34988761; PubMed Central PMCID: PMC11415180.
AÑO: 2023; IF: 3.6
|